IP Library Granted Patent US 8,110,574
Granted Patent B2
US 8,110,574 · App. 12/946,504 · Granted Feb 7, 2012

Derivatives of 4-aminopiperidine and their use as a medicament

Assignee: Ipsen Pharma S.A.S.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,110,574
App. No.
12/946,504
Granted
Feb 7, 2012
Kind
B2
Abstract

A subject of the present application is new derivatives of 4-aminopiperidines of formula in which R 1 , R 2 and R 3 represent various radical, and their preparation processes by synthetic methods in parallel in liquid and solid phase. These products having a good affinity with certain sub-types of somatostatin receptors, they are particularly useful for treating the pathological states or diseases in which one (or more) somatostatin receptors are involved.

Claims (18)

1. Compounds of the general formula:

in racemic, enantiomeric form or all combinations of these forms, in which:

R 1 represents a —(CH 2 ) m —Z 12 radical in which Z 12 represents optionally substituted aryl;

R 2 represents a radical of formula —C(Y)NHX 1 , wherein X 1 represents a (CH 2 ) p Z 22 radical in which Z 22 represents aryl optionally substituted;

R 3 represents an optionally substituted alkyl;

Y represents an oxygen atom;

m is an integer from 1 to 6; and

p is an integer from 0 to 6;

or their addition salts with pharmaceutically acceptable mineral or organic acids.

2. The compound of claim 1 , wherein the aryl represented by Z 12 is substituted with one or more fluoro, chloro, bromo, iodo, alkyl, alkoxy, alkylthio, —CF 3 , —OCF 3 , phenyl, phenoxy or aminosulphonyl.

3. The compound of claim 1 , wherein the aryl represented by Z 22 is substituted with one or more fluoro, chloro, bromo, iodo, alkyl, alkenyl, alkoxy, alkylthio, CF 3 , OCF 3 , nitro, cyano, azido, aminosulphonyl, piperidinosulphonyl, mono- or di-alkylamino, —C(O)—O-alkyl, —C(O)-alkyl, optionally substituted phenyl, phenoxy, phenylthio or benzyloxy.

4. The compound of claim 1 , wherein the aryl represented by Z 12 is substituted with one or more fluoro, chloro, bromo, iodo, alkyl or alkoxy.

5. The compound of claim 1 , wherein the aryl represented by Z 22 is substituted with one or more fluoro, chloro, bromo, iodo, alkyl, alkoxy, alkylthio, CF 3 , OCF 3 , nitro, cyano, azido, piperidinosulphonyl, —C(O)—O-alkyl, —C(O)-alkyl or phenyl.

6. The compound of claim 1 , wherein R 3 is unsubstituted alkyl.

7. The compound of claim 1 , wherein R 3 is methyl.

8. The compound of claim 1 , wherein Z 12 and Z 22 are optionally substituted phenyl or naphthyl.

9. The compound of claim 1 , wherein m and p are simultaneously 1.

10. A pharmaceutical composition comprising a compound of claim 1 or an addition salt thereof with a pharmaceutically acceptable mineral or organic acid.

Priority Claims (1)
FR 99 15724 · Dec 14, 1999 · national
Continuity (4)
Division 12151115 · May 2, 2008
Division 11122293 · May 4, 2005
Division 10130924
Related Publication 20110059971A1 · Mar 10, 2011